Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-13

Clinical Trial Update: Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the efficacy and safety of Cilnidipine plus Valsartan versus Valsartan alone in hypertension; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilnidipine (cilnidipine)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hypertension | Phase 3 | Status: COMPLETED